Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield NM ASO Prior Auth Updates |…
    Ask Trek AI about this page
    ModifiedBlue Cross Blue Shield - New MexicoPolicy N/A

    ASO Specialty Pharmacy prior authorization code list

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - New Mexico policy alerts

    Know when Blue Cross Blue Shield - New Mexico releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Lists procedure/drug codes that require prior authorization for BCBSNM ASO members (medical benefit specialty pharmacy) and indicates which manager (BCBSNM or Carelon) handles each request.

    Policy Summary
    PayerBlue Cross Blue Shield - New Mexico
    PolicyASO Specialty Pharmacy prior authorization code list
    Policy CodePolicy N/A
    Change TypeAdds, retires, and routing clarifications
    Effective DateJan 1, 2024
    Next Review DateN/A
    Key ActionVerify member eligibility and request prior authorization through BCBSNM or Carelon as indicated before providing the service.
    SourceLink
    POLICY UPDATE CHANGES

    Multiple J- and Q- codes were added with effective dates 01/01/2024 or 04/01/2024 and flagged as requiring prior authorization through Carelon.

    Several codes are marked retired effective 04/01/2024.

    Codes representing unclassified drugs/biologics (C9399, J3490, J3590, Q2043, Q2050, etc.) require prior authorization through Carelon.

    manyprocedure/drug codes listed requiring prior authorization
    20+codes requiring Carelon prior authorization in extract
    ≥4codes added effective 04/01/2024 in this extract
    4codes retired effective 04/01/2024 in this extract
    01/01/2024base effective date

    Codes Requiring Prior Authorization & Coverage Rules

    Prior authorization code criteria (examples)

    Prior authorization is required for the following example codes; some entries include effective dates and manager assignments.

    C9163 — Talvey (Talquetamab‑Tgvs); Managed by Carelon; Add Effective 04/01/2024; to be replaced by J3055 effective 07/01/2024; Prior Authorization required through Carelon.
    J3055 — Inj Talquetamab‑Tgvs 0.25 mg; Managed by Carelon; Add Effective 07/01/2024 (replaces C9163 7/1/24); Prior Authorization required through Carelon.
    C9165 — Elrexfio (Elranatamab‑Bcmm); Managed by Carelon; Add Effective 07/01/2024; Prior Authorization required through Carelon.
    J1323 — Inj Elranatamab‑Bcmm 1 mg; Managed by Carelon; Add Effective 04/01/2024; Prior Authorization required through Carelon.
    J0741 — Inj Cabotegravir Rilpivir (provider administered drug therapy); Managed by BCBSNM; Add Effective 07/01/2024; Prior Authorization required through BCBSNM.
    J1961 — Inj Lenacapavir 1 mg; Managed by BCBSNM; Add Effective 07/01/2024; Prior Authorization required through BCBSNM.
    J1551 — Infusion site example; Managed by Carelon or BCBSNM; Carelon will review requests supported by an oncology diagnosis; non‑oncology indications will be reviewed by BCBSNM; Prior Authorization required.

    Carelon prior authorization requirement

    The following codes are assigned to Medical Oncology & Supportive Care and require prior authorization through Carelon unless otherwise noted.

    J0642 — Prior Authorization required through Carelon (Medical Oncology & Supportive Care).
    J0882 — Prior Authorization required through Carelon (Medical Oncology & Supportive Care).
    J0896 — Prior Authorization required through Carelon (Medical Oncology & Supportive Care).
    J0897 — Prior Authorization required through Carelon (Medical Oncology & Supportive Care).
    J9022 — Prior Authorization required through Carelon (Atezolizumab 10 mg).
    J9271 — Prior Authorization required through Carelon (Pembrolizumab).
    J9302 — Prior Authorization required through Carelon (Ofatumumab/Obinutuzumab group).

    BCBSNM prior authorization routing

    Some Q- and related codes require prior authorization through BCBSNM.

    Q5104 — Prior Authorization required through BCBSNM (Renflexis injection).
    Q5121 — Prior Authorization required through BCBSNM (Avsola injection).
    Q5109 — Prior Authorization required through BCBSNM (infusion site examples noted elsewhere).

    Retired codes (operational)

    The following codes are retired and should not be submitted for authorization on or after the effective retire date.

    J9037 — Inj Belantamab Mafodont (Carelon) — Retire Effective 04/01/2024; do not submit for authorization after 2024-04-01.
    J9313 — Inj Lumoxiti 0.01 mg (Carelon) — Retire Effective 04/01/2024; do not submit for authorization after 2024-04-01.
    J9057 — (listed among retired examples in summary) — Retire Effective 04/01/2024; do not submit for authorization after 2024-04-01.
    Q2049 — Code noted as retired Effective 04/01/2024; do not submit for authorization after 2024-04-01.

    Coverage and authorization notes

    General coverage guidance and operational limits related to prior authorization.

    Presence of a code on the prior authorization list does not guarantee coverage; member benefits and eligibility determine coverage.
    Providers are usually responsible for requesting prior authorization before performing a service for in‑network members; some plans may require the member to request PA.
    Once a prior authorization request is received and processed, the decision will be communicated to the provider; call the PA number on the member's ID card for questions.
    Checking eligibility/benefits and prior authorization is not a guarantee of payment; final payment is determined at claim adjudication based on member eligibility and certificate of coverage on date of service.
    This list is not exhaustive; codes may change and the list may be updated throughout the year.

    Coverage and prior authorization notes

    Coverage and prior authorization requirements depend on the member's benefits and eligibility; inclusion on this list does not imply benefit coverage.

    Verify member eligibility and benefits via Availity or the preferred vendor portal before assuming coverage or submitting a prior authorization request.
    Certain listed codes require prior authorization through BCBSNM or through contracted vendors (for example, Carelon) before services are rendered.
    For some services/members, prior authorization may be managed by Blue Cross and Blue Shield of MT or by Carelon Medical Benefits Management per contractual arrangements; check routing before submitting PA.

    HCPCS / J / Q / S Codes and Status

    Infusion Site of Care examplesmixedCovered
    J0485Belatacept Injection
    J0491Anifrolumab-Fnia (Inj)
    Unclassified drug codeHCPCSCovered
    C9399Unclassified drugs/biologics (Code represents unclassified drugs or biologics)
    Selected oncology/supportive-care J-codesHCPCSCovered
    J9022Atezolizumab 10 mg injection
    J9271Pembrolizumab injection
    J9302Ofatumumab injection
    Unclassified drug/biologic codesHCPCSCovered
    C9399Unclassified drugs or biologics
    Q2043Code represents unclassified drugs or biologics (Provenge example)
    Q-code group — oncology/supportive caremixed
    Q2043Unclassified drugs/biologics — prior authorization required through Carelon
    Q2049Code noted as retired effective 04/01/24
    Q2050Doxorubicin Inj 10Mg — prior authorization required through Carelon
    J-code group — gene therapies and high-cost provider-administered drugsmixed
    J1411Hemgenix — added effective 01/01/2024; prior authorization required through BCBS
    J1412Roctavian — added effective 04/01/2024; prior authorization required through BCBS
    J1413Delandistrogene mox — added effective 04/01/2024; prior authorization required through BCBS
    sample HCPCS S-codes listedHCPCS
    S01570.5 Gm. — Prior Authorization required through BCBS
    S0189Goserelin Acetate Implant / Testosterone Pellet 75 Mg — Prior Authorization required through BCBS
    Code replacement effective date
    Effective replacement dateSome C-codes (e.g., C9163) are scheduled to be replaced by J-codes (e.g., J3055) on 07/01/2024.
    Example mappingC9163 to be replaced by J3055 on 07/01/2024.
    Manager for replacementsReplaced codes retain the same manager assignment (Carelon where indicated).
    Codes added with effective dates in this extract
    Adds effective 01/01/2024J9350 is listed as Add Effective 01/01/2024 (prior authorization through Carelon).
    Adds effective 04/01/2024Multiple codes (e.g., J9349, J9332, C9163 added 04/01/2024) are shown with Add Effective 04/01/2024 annotations.
    Adds effective 07/01/2024Several codes (e.g., J3055, J0741, J1961) show Add Effective 07/01/2024 in the list.
    Exhaustiveness
    Non-exhaustive listThis is not an exhaustive list of all codes; codes may change and the list may be updated throughout the year.
    Validate coveragePresence on the list does not guarantee coverage; always verify member benefits and eligibility.
    Updates may occurThe list may be revised during the year to add or retire codes; check for the latest version before submission.

    What Providers Must Do

    Note

    Purpose and routing

    Use this list to identify procedure codes that may require benefit prior authorization through Blue Cross Blue Shield of New Mexico (BCBSNM) ASO; some oncology drug requests that are supported by an oncology diagnosis are managed by Carelon Medical Benefits Management.

    Prior Authorization

    Sample code updates (April/July 2024)

    The listed codes with Add/Update effective dates (for example C9163, J3055, J0741, J1961) were added or updated in April/July 2024 and require prior authorization through the manager indicated (Carelon or BCBSNM).

    • C9163 — Managed by Carelon; Add Effective 04/01/2024; to be replaced by J3055 7/1/24 (PA through Carelon).
    • J3055 — Managed by Carelon; Add Effective 07/01/2024 (PA through Carelon).
    • J0741, J1961 — Managed by BCBSNM; Add Effective 07/01/2024 (PA through BCBSNM).
    Prior Authorization

    Oncology routing rule

    Carelon will review requests for many infusion/oncology drugs when the request is supported by an oncology diagnosis; if the drug is not associated with an oncology diagnosis, the request will be reviewed by BCBSNM.

    • Examples: J1551 and J1554 are noted as 'Carelon or BCBSNM' with the oncology-routing rule described.
    Prior Authorization

    Prior authorization routing (Q/C codes)

    Some Q-codes (e.g., Q5104, Q5121) require prior authorization through BCBSNM; unclassified drug codes (e.g., C9399) represent unclassified drugs/biologics and require prior authorization through Carelon.

    • Q5104, Q5121 — Prior Authorization required through BCBSNM.
    • C9399 — Code represents unclassified drugs/biologics; Prior Authorization required through Carelon.
    Prior Authorization

    J-code prior authorization through Carelon

    The listed J-codes assigned to Medical Oncology & Supportive Care (examples include J0642, J0882, J0896, J2506 and others) require prior authorization through Carelon.

    • J0642, J0882, J0896, J0897, J2506, J2820, J2860, J3490, J3590 — Prior Authorization required through Carelon.
    Documentation Required

    Retired codes (effective 04/01/2024)

    Specified codes are retired effective 04/01/2024 and should not be used for prior authorization after that date.

    • J9037, J9057, J9313, Q2049 — Marked 'Retire Effective 04/01/24.'
    Prior Authorization

    Prior authorization routing — Carelon

    Prior Authorization is required through Carelon for the listed J-codes and their associated specialty drugs (examples include J9354, J9355, J9356, J9358, J9359, J9380).

    • J9354, J9355, J9356, J9358, J9359, J9380 — Prior Authorization required through Carelon.
    Prior Authorization

    Prior authorization routing — BCBSNM and Carelon

    Prior authorization is required through BCBSNM or Carelon depending on the code and diagnosis; Carelon reviews oncology requests linked to an oncology diagnosis, while non-oncology indications are reviewed by BCBSNM.

    • Examples: J9035 and codes representing unclassified drugs may be routed to Carelon for oncology indications and to BCBSNM for non-oncology indications.
    Prior Authorization

    Prior authorization routing — BCBSNM (cell therapies)

    Prior authorization is required through BCBSNM for listed Q-codes that represent CAR-T and other cell therapies (examples include Q2041, Q2042, Q2053–Q2056).

    • Q2041, Q2042, Q2053, Q2054, Q2055, Q2056 — Prior Authorization required through BCBSNM (cell therapies).
    Note

    Prior authorization request responsibility

    Usually, the provider is responsible for requesting prior authorization before performing a service when the member is seeing an in-network provider; in some cases the plan may require the member to request authorization.

    Documentation Required

    Communication of PA decision and contact

    Once a prior authorization request is received and processed, the decision is communicated to the provider; for questions call the prior authorization number on the member's ID card.

    Documentation Required

    Verify eligibility and benefits

    Presence of a code on this list does not guarantee coverage; always verify member eligibility and benefits via Availity® Essentials or your preferred vendor portal before proceeding.

    • Checking eligibility/benefits and/or prior authorization is not a guarantee of payment; final payment is determined at claim adjudication based on the member's coverage at date of service.
    Note

    Utilization management vendors

    Some prior authorizations may be managed by Carelon Medical Benefits Management or by Blue Cross and Blue Shield of Montana depending on the service and member; Carelon is an independent company contracted to provide utilization management services for BCBSNM.

    • For services handled by Carelon, call 1-866-455-8415 or access the Carelon website.

    Key Terms and Vendor Names

    Carelon — Carelon Medical Benefits Management
    DefinitionCarelon Medical Benefits Management (Carelon) — an independent company contracted to provide utilization management services for BCBSNM members.
    Role in documentCarelon handles prior authorization for certain services, particularly many oncology/supportive-care drugs when supported by an oncology diagnosis.
    ContactFor services handled by Carelon, call 1-866-455-8415 or visit the Carelon medical benefits management specialty care web page.
    Oncology routing
    Routing ruleRequests for oncology drugs supported by an oncology diagnosis are reviewed by Carelon; if not associated with an oncology diagnosis, BCBSNM will review.
    Example codesCodes such as J1551 and J1554 are annotated as 'Carelon or BCBSNM' with the oncology-routing note.
    Implication for providersIndication/diagnosis on the prior authorization request determines whether Carelon or BCBSNM reviews the request.
    Carelon prior authorization
    RequirementPrior Authorization required through Carelon for specified codes assigned to Medical Oncology & Supportive Care (e.g., J0642, J2506, J9354).
    Provider actionSubmit prior authorization requests to Carelon for codes managed by Carelon as indicated on the list.
    Carelon-managed examplesJ0642, J2506, J9349, J9354, and many J-codes in the oncology/supportive-care sections are managed by Carelon.
    Unclassified drug/biologic code (C9399, J3490, etc.)
    Unclassified drug/biologic codesCodes such as C9399, J3490, J3590, Q2043 represent unclassified drugs or biologics.
    MeaningThese codes are used for unclassified drugs/biologics or 'Drugs Unclassified Injection' and may list multiple product examples.
    Prior authorization routingUnclassified drug/biologic codes are assigned to Carelon for prior authorization in this document.
    Prior authorization
    DefinitionPrior authorization — a requirement to obtain approval before services are rendered to confirm medical necessity as defined by the member's health benefit plan.
    ResponsibilityUsually the provider is responsible for requesting prior authorization for in-network services; some plans may require the member to request authorization.
    Decision communicationOnce processed, the prior authorization decision is communicated to the provider; call the PA number on the member's ID card with questions.
    Availity
    DefinitionAvaility — an electronic information exchange/portal recommended to check eligibility and benefits prior to requesting services (Availity Essentials / availity.com).
    PurposeUse Availity or preferred vendor portal to confirm coverage, prior authorization requirements, and vendor assignment before submitting requests.
    Separate entityAvaility is a separate company that provides electronic information exchange and administrative services to BCBSNM.
    Prior authorization (purpose and notes)
    PurposePrior authorization is required to confirm medical necessity before services are rendered as defined by the member's health benefit plan.
    Provider responsibilityProviders are usually responsible for requesting prior authorization for in-network services; check member contract for exceptions.
    Not a guarantee of paymentPrior authorization or eligibility checks do not guarantee payment; final determination occurs at claim adjudication based on member coverage on date of service.
    Availity (separate company providing services to BCBSNM)
    Vendor descriptionAvaility is a separate company that operates a health information network to provide electronic information exchange services to medical professionals.
    Role with BCBSNMAvaility provides administrative services to BCBSNM and is used to verify eligibility and benefits.
    Provider actionUse Availity Essentials or preferred web vendor portal to confirm member eligibility, benefits, and PA requirements before requesting services.
    Independent utilization management vendor (Carelon)
    DefinitionAn independent company contracted to provide utilization management and related services for BCBSNM members (Carelon Medical Benefits Management).
    ScopeCarelon manages prior authorization for many oncology/supportive-care drugs and other specialty services as contracted by BCBSNM.
    Contact and noteFor Carelon-managed services call 1-866-455-8415 or visit Carelon's specialty care web page; BCBSNM disclaims endorsement of third-party vendors.
    Policy Summary
    PayerBlue Cross Blue Shield - New Mexico
    PolicyASO Specialty Pharmacy prior authorization code list
    Policy CodePolicy N/A
    Change TypeAdds, retires, and routing clarifications
    Effective DateJan 1, 2024
    Next Review DateN/A
    Key ActionVerify member eligibility and request prior authorization through BCBSNM or Carelon as indicated before providing the service.
    SourceLink
    On This Page
    Codes Requiring Prior Authorization & Coverage RulesHCPCS / J / Q / S Codes and StatusWhat Providers Must DoKey Terms and Vendor Names

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.